COMMUNIQUÉS West-GlobeNewswire

LeMaitre Vascular Will Announce Second Quarter 2018 Earnings Results on July 26, 2018
18/07/2018
BURLINGTON, Mass., July 18, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2018 financial results on Thursday, July 26, 2018, after the market [...]
Resonant Engages LHA for Strategic Investor Relations Services
18/07/2018
GOLETA, Calif., July 18, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ:RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, today announced [...]
Cancer Genetics Closes $2.625 million Convertible Note Financing
18/07/2018
RUTHERFORD, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced the closing of a $ [...]
BioPorto submits FDA application for The NGAL Test™
18/07/2018
July 18, 2018 Announcement no. 13 BioPorto A/S (“BioPorto”) announces today that the company has submitted an application to the US Food and Drug Administration, (“FDA”), for regulatory clearance of The NGAL Test™ for [...]
Amedisys Announces Second Quarter Earnings Release and Conference Call Date
18/07/2018
BATON ROUGE, La., July 18, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), announced today that it will report results for the second quarter ended June 30, 2018 after the market closes on July 31, 2018. The [...]
Health Care Administrators Association (HCAA) Appoints 2018-2019 Board of Directors
18/07/2018
Joanie Verinder to lead self-funding industry initiatives for the association as the new president MINNEAPOLIS, July 18, 2018 (GLOBE NEWSWIRE) -- The Health Care Administrators Association (HCAA) , a leader in education [...]
Tabula Rasa HealthCare Appoints Two New Members to the Board of Directors
18/07/2018
Adds world class healthcare leadership and financial strength MOORESTOWN, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the field [...]
ERPSI Wins $6.6M Contract to Provide TSA with Application Production Support
18/07/2018
ARLINGTON, Va., July 18, 2018 (GLOBE NEWSWIRE) -- The US Department of Homeland Security (DHS) Transportation Security Administration’s (TSA) Applications Development Division (ADD) has awarded Enterprise Resource [...]
William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast
18/07/2018
PHOENIX, July 18, 2018 (GLOBE NEWSWIRE) -- William Hartman, CEO of Premier Biomedical Inc. (OTC PINK:BIEI) ("the Company") joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast. Premier Biomedical currently [...]
Information concerning the total number of voting rights and shares
18/07/2018
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]
Informations relatives au nombre total de droits de vote et d'actions
18/07/2018
Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]
VALNEVA :Transfert à Oddo BHF du contrat de liquidité initialement conclu avec Natixis
18/07/2018
Transfert à Oddo BHF du contrat de liquidité de Valneva initialement conclu avec Natixis Nantes, France, 18 juillet 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée au développement, à la [...]
Novartis Kisqali® now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal women; and as initial therapy with fulvestrant in postmenopausal women
18/07/2018
Kisqali is now the only CDK4/6 inhibitor indicated in combination with an aromatase inhibitor as first-line treatment for pre-, peri- or postmenopausal women with HR+/HER2- advanced breast cancer in the US[1] Kisqali is [...]
JetBlue Airways to Implement ClimaCell’s New HyperCast Aviation Microweather Software to Increase Safety and Efficiency
18/07/2018
New HyperCast Aviation solution designed specifically for airlines and airport operations teams BOSTON, July 18, 2018 (GLOBE NEWSWIRE) -- ClimaCell Ⓡ , the microweather™ technology company that finds and forecasts [...]
Tabula Rasa Healthcare to Announce Second Quarter 2018 Operating Results and Host Conference Call on Tuesday, August 7, 2018
18/07/2018
MOORESTOWN, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company optimizing medication safety, will release its second quarter 2018 operating results on [...]
Athenex Announces Axis Therapeutics Has Entered into a MOU with the Hong Kong Polytechnic University to Set Up a Joint Research Center on Cancer Immunotherapy
18/07/2018
BUFFALO, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Tree of Knowledge Goes Public on the CSE Backed by Strong Management Team and Advisory Board -- CFN Media
18/07/2018
SEATTLE, July 18, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
Devonian Healthcare Group Reports its First ever Revenues: Key Financial Results for Quarter Ended April 30th, 2018
18/07/2018
QUEBEC CITY, July 18, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ( “Devonian” or the “Corporation” ) (TSX VENTURE:GSD), a clinical stage botanical pharmaceutical corporation focused on developing a unique [...]
Groupe Santé Devonian rapporte ses premiers revenus : Résultats Financiers clés pour le trimestre terminé le 30 avril 2018
18/07/2018
QUÉBEC, 18 juill. 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. ( « Devonian » ou la « Soci é t é » ) (TSX CROISSANCE:GSD), une société pharmaceutique botanique en stade avancé de développement axée sur l’ [...]

Pages